WHY IT MATTERS
          The inability to obtain these insights makes it impossible to capture a therapy's comprehensive impact, affecting payer formulary/market access decisions.
          CHALLENGE #10
            HCRU & Cost Analyses
            
             
              >50% of teams report it is a "significant to very significant challenge" to obtain:
- 
Payer cost data
- 
Hospitals' itemized charge data
- 
Longitudinal enrollment coverage at the patient level
- 
HCRU by setting of care
- 
Patient insurance assignment/status
What’s behind the challenge? 
- 
No access to a comprehensive data source that tracks the patient journey — across HCPs, HCOs, care settings, and payers — capturing switches in patient insurance
- 
Lack of access to coverage/cost data for treatments, procedures, products, and services
- 
Using data that doesn’t include all payers or includes payers but not health plan type (e.g., PPO vs. high deductible or Medicare FFS vs. Medicare Advantage)
- 
No access to patient enrollment data to confirm the payer coverage listed on claims
 
         
          .png)